Stephen Wargacki insider trades
Open-market stock purchases and sales by Stephen Wargacki, Chief Science Officer at Aquestive Therapeutics, Inc, from SEC Form 4 filings since Mar 9, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- AQST Aquestive Therapeutics, Inc: other filings, last Mar 10, 2025